好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Impact of the Severity of the Cervical Lesion in Patients with Tandem Lesions Following Endovascular Treatment
Cerebrovascular Disease and Interventional Neurology
P6 - Poster Session 6 (5:00 PM-6:00 PM)
5-018

To evaluate whether the severity of the cervical lesion (occlusion vs. stenosis) in tandem lesions (TLs) affects angiographic and clinical outcomes following endovascular treatment (EVT).

Tandem lesions involve simultaneous intracranial large vessel occlusion and steno-occlusive disease of the ipsilateral cervical artery. Prior studies suggest that complete occlusion may result in lower recanalization rates and worse outcomes compared with stenosis. However, evidence remains inconclusive. This meta-analysis investigates the impact of cervical lesion severity on reperfusion success, functional recovery, and hemorrhagic complications in TLs undergoing EVT.

A comprehensive literature search was performed across PubMed, Embase, and Cochrane databases through June 2025. Studies comparing outcomes between TL patients with cervical occlusion versus stenosis after EVT were included. Outcomes of interest were successful recanalization (mTICI ≥2b), good functional outcome (modified Rankin Scale [mRS] 0–2 at 90 days), parenchymal hemorrhage, and 90-day mortality. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model, with heterogeneity assessed by I² statistics.

Three studies (n=670; 328 occlusion, 342 stenosis) met inclusion criteria. No significant differences were observed in successful recanalization (RR 0.87; 95% CI 0.55–1.39; p=0.34), good functional outcome (RR 0.94; 95% CI 0.79–1.13; p=0.29), or 90-day mortality (RR 1.01; 95% CI 0.64–1.57; p=0.96). However, parenchymal hemorrhage was significantly lower in the occlusion group (RR 0.76; 95% CI 0.60–0.97; p=0.04).

In TLs treated with EVT, cervical occlusion was associated with similar angiographic and functional outcomes compared with stenosis, but with a lower risk of parenchymal hemorrhage. These findings suggest that cervical lesion severity may not significantly influence reperfusion or recovery but may affect hemorrhagic risk profiles.

Authors/Disclosures
Biniyam Mulatu, MD
PRESENTER
Dr. Mulatu has nothing to disclose.
Wei Jun Lee No disclosure on file
Rafaela Correia Maciel Miss Correia Maciel has nothing to disclose.
Tam Q. Tran, MD Dr. Tran has nothing to disclose.
Aashish Baniya, MBBS (Suny Downstate) Dr. Baniya has nothing to disclose.
Adam Dmytriw (Massachusetts General Hospital) Adam Dmytriw has nothing to disclose.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.